Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841062 | 12484106 | 2 | F | 20160630 | 20160621 | 20160711 | EXP | FR-MLMSERVICE-20160604-0305365-1 | FR-ACCORD-041631 | ACCORD | MAGREAULT S, VODOVAR D, DEYE N, VOICU S, MALISSIN I, GOURY A ET AL. LIFE-THREATENING AMLODIPINE INTOXICATION: A COMPARISON OF TWO APPROACHES TO TREATMENT. CLINICAL TOXICOLOGY, 2016; 54(4):474. | 51.00 | YR | F | Y | 0.00000 | 20160711 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124841062 | 12484106 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 202553 | 3.6 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124841062 | 12484106 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124841062 | 12484106 | HO |
| 124841062 | 12484106 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124841062 | 12484106 | Overdose | |
| 124841062 | 12484106 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |